When chemicals that are nongenotoxic in conventional assays produce increases in tumor incidence in rodents in chronic bioassays, the determination of the significance of these data for human safety is a challenging task. An important first step in this process is consideration of available data on the mechanism of action and biological properties of the chemical as well as pharmacokinetic and metabolism data in the species showing the response. In recent years, there has been an increase in the understanding of so-called “secondary mechanisms” of carcinogenesis (e.g., thyroid tumors in rats following exposure to enzyme inducers). Application of these data may assist in determination of human risk. There are 2 important questions that will be explored and developed: Are there biological effects produced in the test species that could explain the increase in tumor incidence, and will these effects be reproduced in humans? What is the exposure to the chemical that is associated with the increase in tumors, and how does this relate to exposure in humans?
1. Akaza H, Murphy WM, and Soloway MS (1984). Bladder cancer induced by noncarcinogenic substances.J. Urol.131: 152–155.
2.
2. Albert DM, Frayer WC, Black HE, Massicotte SJ, Sang DN, and Soque J (1986). The Harderian gland: Its tumors and its relevance to humans.Trans. Am. Ophthalmol. Soc.84: 321–341.
3.
3. Alden CL (1986). A review of unique male rat hydrocarbon nephropathy.Toxicol. Pathol.14: 109–111.
4.
4. Alden CL, Ridder G, and Stone L (1984). The pathogenesis of the nephrotoxicity of volatile hydrocarbons in the male rat. In: Renal Effects of Petroleum Hydrocarbons, MA Mehlman, GP Hemstreet, JJ Thorpe, and NK Weaver (eds). Princeton Scientific Publishers, Princeton, New Jersey, pp. 107–120.
5.
5. Altmann H-J, Wester PW, Matthiaschk G, Grunow W, and van der Heijden CA (1985). Induction of early lesions in the forestomach of rats by 3-tert- butyl-4-hydroxyanisol (BHA).Fd. Chem. Toxicol.23: 723–734.
6.
6. Axelrod AA and Leblond CP (1955). Induction of thyroid tumors in rats by a low iodine diet.Cancer8: 339–367.
7.
7. Betton GR, Dormer CS, Wells T, Pert P, Price CA, and Buckley P (1988). Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK&F 93479 and oxmetidine and omeprazole.Toxicol. Pathol.16: 288–298.
8.
8. Birnbaum LS (1993). The mechanism of dioxin toxicity: Relationship to risk assessment. Environ. Health Perspect. (in press).
9.
9. Boas NF and Bates RW (1954). Role of the thyroid and anterior pituitary glands in the maintenance of the Harderian glands of the rat.Endocrinology55: 601–612.
10.
10. Borghoff SJ, Miller AB, Bowen JP, and Swenberg JA (1991). Characteristics of chemical binding to α2u-globulin in vitro-evaluating structure-activity relationships.Toxicol. Appl. Pharmacol.107: 228–238.
11.
11. Brunner GHG, Lamberts R, and Creutzfeldt W (1990). Efficacy and safety of omeprazole in the long- term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.Digestion47: 64–68.
12.
12. Charbonneau M, Lock EA, Strasser J, Cox MG, Turner MJ, and Bus JS (1987). 2,2,4-Trimethylpentane-induced nephrotoxicity. I. Metabolic disposition of TMP in male and female Fischer 344 ratsToxicol. Appl. Pharmacol.91: 171–181.
13.
13. Charbonneau M, Strasser J, Lock EA, Turner MJ, and Swenberg JA (1989). Involvement of reversible binding to α2u-globulin in 1,4-dichlorobenzene-induced nephrotoxicity.Toxicol. Appl. Pharmacol.99: 122–132.
14.
14. Clayson D and Cooper EH (1970). Cancer of the urinary bladder.Adv. Cancer Res.13: 271–381.
15.
15. Clayson DB (1974). Bladder carcinogenesis in rats and mice: Possibility of artifacts.J. Natl. Cancer Inst.52: 1685–1689.
16.
16. Clayson DB, Iverson F, Nera EA, and Lok E (1990). The significance of induced forestomach tumors.Annu. Rev. Pharmacol. Toxicol.30: 441–463.
17.
17. Clemmesen J, Fuglsang-Frederiksen V, and Plum CM (1974). Are anticonvulsants oncogenic?Lancet1: 705–707.
18.
18. Cockburn ITR and Krupp P (1989). The risk of neoplasms in patients treated with cyclosporine A.J. Autoimmunol.2: 723–731.
19.
19. Cohen SM, Cano M, Earl RA, Carson SD, and Garland EM (1991). A proposed role for silicates and protein in the proliferative effects of saccharin on the male rat urothelium.Carcinogenesis12: 1551–1555.
20.
20. Cohen SM and Ellwein LB (1991). Genetic errors, cell proliferation, and carcinogenesis.Cancer Res.51: 6493–6505.
21.
21. Colbert E, Wilson BF, Williams GD, and Williams PD (1990). Relationship between in vitro relaxation of the costo-uterine smooth muscle (COSM) and mesovarial leiomyoma formation in vivo. Presented at New Horizons in Molecular Toxicology, Poster Session Program, Eli Lilly and Company, Indianapolis, Indiana, May 21.
22.
22. De Groot AP, Feron V, and Immel H (1988). Induction of hyperplasia in the bladder epithelium of rats by a dietary excess of acid or base: Implications for toxicity/carcinogenicity testing.Fd. Chem. Toxicol.26: 425–434.
23.
23. Dent JN, Godsden EL, and Furth J (1956). Further studies on induction and growth of thyrotropic pituitary tumors in mice.Cancer Res.16: 171–174.
24.
24. Dietrich DR and Swenberg JA (1991). Alpha α2u- globulin is necessary for d-limonene promotion of male rat kidney tumors.Cancer Res.51: 3512–3521.
25.
25. Dietrich DR and Swenberg JA (1991). NCI-Black- Reiter (NBR) male rats fail to develop renal disease following exposure to agents that induce α2u-globulin (α2u) nephropathy.Fund. Appl. Toxicol.16: 749–762.
26.
26. Eason CT, Pattison A, Howels DD, and Bonner FW (1988). The effect of ciprofibrate on gastric secretion in the rat.J. Pharm. Pharmacol.40: 512–513.
27.
27. Ekman L, Hansson E, Havu N, Carlsson E, and Lunberg C (1985). Toxicological studies on omeprazole.Scand. J. Gastroenterol.20: 53–69.
28.
28. Ellwein LB and Cohen S (1990). The health risk of saccharin revisited.Crit. Rev. Tox.20: 311–326.
29.
29. Emerson CH, Cohen JH III, Young RA, Alex S, and Fan S-L (1990). Gender-related differences of serum thyroxine-binding proteins in the rat.Acta Endocrinol.123: 72–78.
30.
30. Ewing LL (1989). The trophic effect of luteinizing hormone on the rat Leydig cell.J. Am. Coll. Toxicol.8: 473–485.
31.
31. FDA Advisory Committee Report on Antipsychotic Drugs (August 12, 1977).
32.
32. Fitzgerald JE, Sanyer JL, Schardein JL, Lake RS, McGuire EJ, and de la Iglesia FA (1981). Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent gemifbrozil.J. Natl. Cancer Inst.67: 1105–1116.
33.
33. Fukushima S, Imarida K, Shibata M, Tamano S, Kurata Y, and Shirai T (1988). L-ascorbic acid amplification of second-stage bladder carcinogenesis promotion by NaHCO3.Cancer Res.48: 6317–6320.
34.
34. Gerson RJ, MacDonald JS, Alberts AW, Kornbrust DJ, Majka JA, Stubbs RJ, and Bokelman DL (1989). Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors. Am. J. Med.87: 4A–28S–4A–38S.
35.
35. Gibson JP, Sells DM, Cheng HC, and Yuh L (1987). Induction of uterine leiomyomas in mice by medroxalol and prevention by propranolol.Toxicol. Pathol.15: 468–473.
36.
36. Green S (1991) Receptor-mediated non-genotoxic carcinogenesis: New models for risk assessment?Human Exp. Tox.10: 390–395.
37.
37. Grice HC (1988). Safety evaluation of butylated hydroxyanisole from the perspective of effects on forestomach and oesophageal squamous epithelium.Fd. Chem. Toxicol.26: 717–723.
38.
38. Håkanson R, Larsson L-I, Liedberg G, and Sundler F (1976). The histamine-storing enterochromaffin- like cells of the rat stomach. In: Chromaffin, Enterochromaffin & Related Cells, RE Coupland and T Fujita (eds). Elsevier Scientific Publishing Company, pp. 243–263.
39.
39. Handschumacher RE, Harding MW, Rice J, and Drugge RJ (1984). Cyclophillin: A specific cytosolic binding protein for cyclosporin A.Science226: 544–546.
40.
40. Hard GC, Rodgers IS, Baetcke KP, Richards WL, McGaughy RE, and Valcovic LR (1993). Hazard evaluation of chemicals that cause accumulation of α2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats.Environ. Health Perspect.99: 313–349.
41.
41. Hattori A, Perera MI, Witkowski LA, Kunz HW, Gill TJ III, and Shinozuka H (1986). Accelerated development of spontaneous thymic lymphomas in male AKR mice receiving cyclsporine.Transplantation41: 784–786.
42.
42. Havu N, Mattsson H, Ekman L, and Carlsson E (1990). Enterochromaffin-like cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine.Digestion45: 189–195.
43.
43. Herbold DR, Fu YS, and Silbert SW (1983). Leiomyosarcoma of the broad ligament. A case report and literature review with follow-up.Am. J. Surg.7: 285–292.
44.
44. Hill RN, Erdreich LS, Paynter OE, Roberts PA, Rosenthal SL, and Wilkinson CF (1989). Review. Thyroid follicular cell carcinogenesis.Fund. Appl. Toxicol.12: 629–697.
45.
45. Hirth RS, Evans LD, Buroker RA, and Oleson FB (1988). Gastric enterochromaffin-like cell hyperplasia and neoplasia in the rat: An indirect effect of the histamine H2-receptor antagonist, BL-6341.Toxicol. Pathol.16: 273–287.
46.
46. Hoffman RA, Wertz P, and Habeeb P (1989). Harderian glands of golden hamsters: Morphological and biochemical responses to thyroid hormones.J. Comp. Physiol. B159: 293–299.
47.
47. Huff JE, Salmon AG, Hooper NK, and Zeise L (1991). Long-term carcinogenesis studies on 2,3,7,8- tetrachlorodibenzo-p-dioxin and hexachlorodibenzo-p-dioxins.Cell Biol. Toxicol.7: 67–94.
48.
48. Issemann I and Green S (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferation.Nature (London)347: 645–650.
49.
49. Ito N and Fukushima S (1989). Promotion of urinary bladder carcinogenesis in experimental animals.Exp. Pathol.36: 1–15.
50.
50. Ito N, Fukushima S, Hagiwara A, Shibata M, and Ogiso T (1983). Carcinogenicity of butylated hydroxyanisole in F344 rats.J. Natl. Cancer Inst.70: 343–352.
51.
51. Ito N, Fukushima S, Tamano S, Hirose M, and Hagiwara A (1986). Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.J. Natl. Cancer Inst.77: 1261–1265.
52.
52. Iverson F, Truelove J, Nera E, Wong J, Lok E, and Clayson DB (1985). An 85-day study of butylated hydroxyanisole in the cynomolgus monkey.Cancer Lett.26: 43–50.
53.
53. Jack D, Poynter D, and Spurling NW (1983). Betaadrenoceptor stimulants and mesovarian leiomyomas in the rat.Toxicology27: 317–320.
54.
54. Jull JW (1976). Endocrine aspects of carcinogenesis. In: Chemical Carcinogens, CE Searle (ed). American Chemical Society Monograph 173. American Chemical Society, Washington, D.C., pp. 52–82.
55.
55. Kasama K, Blank ML, and Synder F (1989). Identification of 1-alkyl-2-acyl-3-(2',3'-diacylglycerol)glycerols, a new type of lipid class, in Harderian gland tumors of mice.J. Biol. Chem.16: 9453–9461.
56.
56. Kennedy TH and Purves HD (1941). Studies on experimental goitre. I. The effects of Brassica seed diets on rats.Brit. J. Exp. Pathol.22: 241–247.
57.
57. Kloss MW, Cox MG, Norton RM, Swenberg JA, and Bus JS (1985). Sex-dependent differences in the disposition of [14C]-2,2,4-trimethylpentane in Fischer-344 rats. In: Renal Heterogeneity and Target Cell Toxicity, PH Back and EA Lock (eds). John Wiley & Sons, Chichester, pp. 489–492.
58.
58. Kloss MW, Patrick DH, and MacDonald JS (1991). Studies on the effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the rodent forestomach.Fd. Chem. Toxicol.29: 621–628.
59.
59. Krieg T, Goerz G, Lissner R, Bolsen K, and Ullrich V (1978). Drug monooxygenase activity in the Harderian gland.Biochem. Pharmacol.27: 575–577.
60.
60. Kroes R and Wester PW (1986). Forestomach carcinogens: Possible mechanisms of action.Fd. Chem. Toxicol.24: 1083–1089.
61.
61. Kurokawa Y, Matsushima Y, Imazawa T, Takamura N, Maekawa A, Takahashi M, and Hayashi Y (1986). Long-term in vivo carcinogenicity study of nalidixic acid in CDF1 mice.Fd. Chem. Toxicol.24: 319–323.
62.
62. Landers JP and Bunce NJ (1991). The Ah receptor and the mechanism of dioxin toxicity.Biochem. J.276: 273–287.
63.
63. Lankas GR and Peter C (1992). Induction of reversible urothelial cell hyperplasia in rats by clorsulon, a flukicide with weak carbonic anhydrase inhibitory activity.Fd. Chem. Toxicol.30: 297–306.
64.
64. Larsson H, Carlsson E, Håkanson R, Mattsson H, Nilsson G, Seensalu R, Wallmark B, and Sundler F (1988). Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats.Gastroenterology95: 1477–1486.
65.
65. Lehman-McKeeman LD and Caudill D (1992). Biochemical basis for mouse resistance to hyaline droplet nephropathy: Lack of relevance of the α2u-globulin protein superfamily in this male rat-specific syndrome.Toxicol. Appl. Pharmacol.112: 214–221.
66.
66. Lehman-McKeeman LD and Caudill D (1992). α2u- Globulin is the only member of the lipocalin protein superfamily that binds to hyaline droplet inducing agents.Toxicol. Appl. Pharmacol.116: 170–176.
67.
66. Lehman-McKeeman LD, Caudill D, Takigiku R, Schneider RE, and Young JA (1989). d-Limonene- induced male rat-specific nephrotoxicity: Evaluation of the association between d-limonene and α2u- globulin.Toxicol. Appl. Pharmacol.99: 250–259.
68.
67. Lehman-McKeeman LD, Rivera-Torres MI, and Caudill D (1990). Lysosomal degradation of α2u- globulin and α2u-globulin-xenobiotic conjugates.Toxicol. Appl. Pharmacol.103: 539–548.
69.
69. Leslie GB, Noakes DN, Pollitt FD, Roe FJC, and Walker TF (1981). A two-year study with cimetidine in the rat: Assessment for chronic toxicity and carcinogenicity.Toxicol. Appl. Pharmacol.61: 119–137.
70.
70. Littlefield NA, Blackwell B-N, Hewitt CC, and Gaylor DW (1985). Chronic toxicity and carcinogenicity studies of gentian violet in mice.Fund. Appl. Toxicol.5: 902–912.
71.
71. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, and Schreiber SL (1991). Calcineurin is a common target of cyclosphilin-cyclosporine A and FKBP-FK506 complexes.Cell66: 807–815.
72.
72. Lossius K and Nesheim BI (1976). Response to isoprenaline in the human pregnant and non-pregnant myometrium.Acta Pharmacol. Toxicol.39: 198–208.
73.
73. MacDonald JS, Gerson RJ, Kornbrust DJ, Kloss MW, Prahalada S, Berry PH, Alberts AW, and Bokelman DL (1988). Preclinical evaluation of lovastatin. Am. J. Cardiol.62: 16J–27J.
74.
74. MacFarland HN, Ulrich CE, Holdsworth CE, Kitchen DN, Halliwell WH, and Blum SC (1984). A chronic inhalation study with unleaded gasoline vapor.J. Am. Coll. Toxicol.3: 231–248.
75.
75. Madhukar BV, Brewster DW, and Matsumura F (1984). Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamster.Proc. Natl. Acad. Sci. USA81: 7407–7411.
76.
76. Maltoni C, Lefemine G, Ciliberti A, Cotti G, and Carretti D (1981). Carcinogenicity bioassays of vinyl chloride monomer: A model of risk assessment on an experimental basis.Environ. Health Perspect.41: 3–29.
77.
77. Matter BE, Donatsch P, Racine RR, Schmid B, and Suter W (1982). Genotoxicity evaluation of cyclosporin A, a new immunosuppressive agent.Mut. Res.105: 257–264.
78.
78. Mattsson H, Havu N, Bräutigam J, Carlsson K, Lundell L, and Carlsson E (1991). Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat.Gastronterology100: 311–319.
79.
79. McClain RM (1989). The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: Implications for thyroid gland neoplasia.Toxicol. Pathol.17: 294–306.
81. Melnick RL, Boorman GA, Haseman JK, Montali RJ, and Hoff J (1984). Urolithiasis and bladder carcinogenicity of melamine in rodents.Toxicol. Appl. Pharmacol.72: 292–303.
82.
82. Monro A (1993). The paradoxical lack of interspecies correlation between plasma concentrations and chemical carcinogenicity.Reg. Toxicol. Pharmacol.18: 115–135.
83.
83. Nagasawa H, Chen C-L, and Meites J (1973). Relation between growth of carcinogen-induced mammary cancer and serum prolactin values in rats.Proc. Soc. Exp. Biol. Med.142: 625–627.
84.
84. Nelson LW and Kelly WA (1971). Mesovarial leiomyomas in rats in a chronic toxicity study of soterenol hydrochloride.Vet. Pathol.8: 452–457.
85.
85. Nelson LW, Kelly WA, and Weikel JH Jr (1972). Mesovarial leiomyomas in rats in a chronic toxicity study of mesuprine hydrochloride.Toxicol. Appl. Pharmacol.23: 731–737.
86.
86. Nera EA, Iverson F, Lok E, Armstrong CL, Karpinski K, and Clayson DB (1988). A carcinogenesis reversibility study of the effects of butylated hydroxyanisole on the forestomach and urinary bladder in male Fischer 344 rats.Toxicology53: 251–268.
87.
87. Physicians Desk Reference (1993). Eulexin (flutamide). Economics Company, Montvale, New Jersey, pp. 2185–2186.
88.
88. Physicians Desk Reference (1993). Imuran (azathioprine). Medical Economics Company, Montvale, New Jersey, pp. 785–787.
89.
89. Physicians Desk Reference (1993). Purinethol (mercaptopurine). Economics Company, Montvale, New Jersey, pp. 820–822.
90.
90. Port CD, Dodd DC, Deslex P, Regnier B, Sanders P, and Indacochea-Redmond N (1987). Twentyone- month evaluation of misoprostol for carcinogenicity in CD-I mice.Toxicol. Pathol.15: 134–142.
91.
91. Poynter D, Pick CR, Harcourt RA, Selway SAM, Ainge G, Harman IW, Spurling NW, Fluck PA, and Cook JL (1985). Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat.Gut26: 1284–1295.
92.
92. Prahalada S, Majka JA, Soper KA, Nett TM, Bagdon WJ, Peter CP, Burek JD, MacDonald JS, and van Zwieten MJ (1994). Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5α- reductase inhibitor: Possible mechanism.Fund. Appl. Toxicol.22: 211–219.
93.
93. Quadri SK, Kledzik GS, and Meites J (1973). Effects of L-dopa and methyldopa on growth of mammary cancers in rats.Proc. Soc. Exp. Biol. Med.142: 759–761.
94.
94. Reddy JK (1990). Carcinogenicity of peroxisome proliferators: Evaluation and mechanisms.Biochem. Soc. Trans.18: 92–94.
95.
95. Roberts SA, Nett TM, Hartman HA, Adams TE, and Stoll RE (1989). SDZ 200–110 induces Leydig cell tumors by increasing gonadotropins in rats.J. Am. Coll. Toxicol.8: 487–505.
96.
96. Ryan RP, Sunahara GI, Lucier GW, Birnbaum LS, and Nelson KG (1989). Decreased ligand binding to the hepatic glucocorticoid and epidermal growth factor receptors after 2,3,4,7,8-pentachlorodibenzofuran and 1,2,3,4,7,8-hexachlorodibenzofuran treatment of pregnant mice.Toxicol. Appl. Pharmacol.98: 454–464.
97.
97. Ryberg B, Carlsson E, Carlsson K, Håkanson R, Lundell L, Mattsson H, and Sundler F (1990). Effects of partial resection of acid-secreting mucosa on plasma gastrin and enterochromaffin-like cells in the rat stomach.Digestion45: 102–108.
98.
98. Ryffel B (1992). The carcinogenicity of ciclosporin.Toxicology73: 1–22.
99.
99. Ryffel B, Donatsch P, Madorin M, Matter BE, Rüttimann G, Schön H, Stoll R, and Wilson J (1983). Toxicological evaluation of cyclosporin A.Arch Toxicol.53: 107–141.
100.
100. Sakai T (1981). The mammalian Harderian gland: Morphology, biochemistry, function and phylogeny.Arch. Histol. Jap.44: 299–333.
101.
101. Sarkar DK, Gottschall PE, and Meites J (1982). Damage to hypothalmic dopaminergic neurons associated with development of prolactin-secreting pituitary tumors.Science218: 684–686.
102.
102. Schyve PM, Smithline F, and Meltzer HY (1978). Neuroleptic-induced prolactin level elevation and breast cancer.Arch. Gen. Psychiatry35: 1291–1301.
103.
103. Sheldon WG, Curtis M, Kodell RL, and Week L (1983). Primary Harderian gland neoplasms in mice.J. Natl. Cancer Inst.71: 61–68.
104.
104. Shibata MA, Tamano S, Kurata Y, Hagiwara A, and Fukushima S (1989). Participation of urinary Na+, K+, pH and L-ascorbic acid in the proliferative response of the bladder epithelium after the oral administration of various salts and/or ascorbic acid to rats.Fd. Chem. Toxicol.27: 403–413.
105.
105. Shirama K, Furuya T, Takeo Y, Shimizu K, and Maekawa K (1981). Influences of some endocrine glands and of hormone replacement on the porphyrins of the Harderian glands of mice.J. Endocrinol.91: 305–311.
106.
106. Short BG, Burnett VL, Cox MG, Bus JS, and Swenberg JA (1987). Site-specific renal cytotoxicity and cell proliferation in male rats exposed to petroleum hydrocarbons.Lab. Invest.57: 564–577.
107.
107. Short BG, Burnett VL, and Swenberg JA (1986). Histopathology and cell proliferation induced by 2,2,4-trimethylpentane in the male rat kidney.Toxicol. Pathol.14: 194–203.
108.
108. Singh SP and McKenzie JM (1969). Effects of thyrotropin on 35S-sulfate uptake by mouse Harderian gland.Endocrinology85: 952.
109.
109. Solcia E, Rindi G, Havu N, and Elm G (1989). Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole.Scand. J. Gastroneterol.24: 129–137.
110.
110. Starzl TE, Porter KA, Iwatsuki S, Rosenthal JT, Shaw BW Jr, Atchison RW, Nalesnik MA, Ho M, Griffin BP, Hakala TR, Hardesty RL, Jaffe R, and Bahnson HT (1984). Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.Lancet1: 583–587.
111.
111. Stott WT (1988). Chemically induced proliferation of peroxisomes: Implications for risk assessment.Reg. Toxicol. Pharmacol.8: 125–159.
112.
112. Sundler F, Håkanson R, Carlsson E, Larsson H, and Mattsson H (1986). Hypergastrinemia after blockade of acid secretion in the rat: Trophic effects.Digestion35: 56–69.
113.
113. Swenberg JA, Short B, Borghoff S, Strasser J, and Charbonneau M (1989). The comparative pathobiology of α2u-globulin nephropathology.Toxicol. Appl. Pharmacol.97: 35–46.
114.
114. USEPA (1991). Alpha2u-Globulin: Association with Chemically Inducted Renal Toxicity and Neoplasia in the Male Rat. EPA/62a5/3–91/019F. U.S. Environmental Protection Agency, Washington, D.C.
115.
115. Viguier-Martinez MC, Hochereau de Reviers MT, Barenton B, and Perreau C (1983). Endocrinological and histological changes induced by flutamide treatment on the hypothalamo-hypophyseal testicular axis of the adult male rat and their incidences on fertility.Acta Endocrinol.104: 246–252.
116.
116. Walsh JH (1987). Gastrointestinal hormones. In: Physiology of the Gastrointestinal Tract, 2nd ed., LR Johnson (ed). Raven Press, New York, pp. 181–253.
117.
117. Walsh JH (1990). Role of gastrin as a trophic hormone.Digestion47: 11–16.
118.
118. Watanabe M (1980). An autoradiographic, biochemical, and morphological study of the Harderian gland of the mouse.J. Morphol.163: 349–365.
119.
119. Weisburger EK (1983). History of the bioassay program of the National Cancer Institute.Prog. Exp. Tumor Res.26: 187–201.
120.
120. Weisburger EK, Murthy ASK, Lilja HS, and Lamb JC IV (1984). Neoplastic response of F344 rats and B6C3F1 mice to the polymer and dyestuff intermediates 4,4'-methylenebis(N,N-dimethyl)-benzenamine, 4,4'-oxydianiline, and 4,4'-methylenedianiline.J. Natl. Cancer Inst.72: 1457–1463.
121.
121. Welsch CW and Nagasawa H (1977). Prolactin and murine mammary tumorigenesis: A review.Cancer Res.37: 951–963.
122.
122. Whitlock JP Jr (1990). Genetic and molecular aspects of 2,3,7,8-tetra-chlorodibenzo-p-dioxine action.Annu. Rev. Pharmacol. Toxicol.30: 251–277.
123.
123. Whitlock JP Jr (1991). Mechanism of dioxin action: Relevance to risk assessment. In: Banbury Report 35: Biological Basis for Risk Assessment of Dioxins and Related Compounds, MA Gallo, RJ Scheuplein, and KA van der Heijden (eds). Cold Spring Harbor Laboratory Press, New York, pp. 351–359.
124.
124. Wilkinson AH, Smith JL, Hunsicker LG, Tobacman J, Kapelanski DP, Johnson M, Wright FH, Behrendt DM, and Corry RJ (1989). Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisolone.Transplantation47: 293–296.
125.
125. Wilson JT, Hauser RE, and Ryffel B (1985). Osteomas in OF-1 mice: No alteration in biologic behavior during long-term treatment with cyclosporine.J. Natl. Cancer Inst.75: 897–901.
